08/27/2024 3:45 PM | ClearPoint Neuro, Inc. (Subject) ClearPoint Neuro, Inc. (Subject) PTC Therapeutics (Filed by)
| Form SC 13D/A | |
08/08/2024 3:35 PM | PTC Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/18/2024 4:20 PM | Gravier Pierre (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/16/2024 2:14 PM | Gravier Pierre (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024 6:00 AM | PTC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2024 6:55 AM | PTC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/24/2024 4:20 PM | PTC Therapeutics (Issuer) ZELDIS JEROME B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/22/2024 9:12 AM | PTC Therapeutics (Subject) ZELDIS JEROME B (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 6:20 AM | PTC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/10/2024 4:20 PM | PTC Therapeutics (Issuer) SOUTHWELL DAVID P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2024 4:20 PM | Golden Lee Scott (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 2:30 PM | Golden Lee Scott (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/22/2024 4:20 PM | Klein Matthew B. (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 4:20 PM | Klein Matthew B. (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 4:20 PM | Pauwels Eric (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 2:17 PM | Klein Matthew B. (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024 2:24 PM | Pauwels Eric (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024 2:13 PM | Klein Matthew B. (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024 4:16 PM | Golden Lee Scott (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 2:58 PM | Golden Lee Scott (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 3:36 PM | PTC Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/16/2024 3:20 PM | PTC Therapeutics (Issuer) SOUTHWELL DAVID P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:20 PM | Bell William F. Jr. (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:25 PM | PTC Therapeutics (Issuer) SCHMERTZLER MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:10 PM | Boulding Mark Elliott (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:10 PM | Klein Matthew B. (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:10 PM | Golden Lee Scott (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:11 PM | Gravier Pierre (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:16 PM | Okey Stephanie (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 2:50 PM | ARMISTICE CAPITAL, LLC (Filed by) PTC Therapeutics (Subject)
| Form SC 13G | |
02/14/2024 6:13 AM | PTC Therapeutics (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/08/2024 9:17 AM | PTC Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/30/2024 2:17 PM | PTC Therapeutics (Subject) Utter Christine Marie (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024 2:18 PM | Almstead Neil Gregory (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024 2:18 PM | Almstead Zheng Yang (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024 2:25 PM | Pauwels Eric (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024 3:30 PM | Jacobson Allan Steven (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 12:11 PM | PTC Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024 3:11 PM | Jacobson Allan Steven (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024 3:06 PM | Golden Lee Scott (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 3:08 PM | Klein Matthew B. (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
War on Elon Escalates… (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9244&Placement=NativeDisplay&Source=NativeDisplay) One company holds a near-total monopoly on it. |
01/10/2024 3:09 PM | Pauwels Eric (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 3:10 PM | PTC Therapeutics (Issuer) SCHMERTZLER MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 3:11 PM | PTC Therapeutics (Issuer) Utter Christine Marie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 7:53 AM | FMR LLC (Filed by) PTC Therapeutics (Subject)
| Form SC 13G/A | |
01/09/2024 4:46 PM | Almstead Zheng Yang (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 3:35 PM | Klein Matthew B. (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 3:29 PM | Klein Matthew B. (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:30 PM | Golden Lee Scott (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 3:33 PM | Pauwels Eric (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 3:16 PM | Almstead Neil Gregory (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 3:17 PM | Boulding Mark Elliott (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024 3:23 PM | PTC Therapeutics (Subject) Utter Christine Marie (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 3:47 PM | Almstead Zheng Yang (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 3:35 PM | BlackRock Inc. (Filed by) PTC Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024 3:37 PM | Almstead Neil Gregory (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 3:46 PM | PTC Therapeutics (Subject) Utter Christine Marie (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 3:29 PM | Boulding Mark Elliott (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 3:34 PM | Klein Matthew B. (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 3:35 PM | Golden Lee Scott (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 8:46 AM | PTC Therapeutics (Subject) SCHMERTZLER MICHAEL (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 8:27 AM | PTC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2024 2:17 PM | Klein Matthew B. (Reporting) PTC Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/28/2023 4:12 PM | Klein Matthew B. (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 3:38 PM | Gravier Pierre (Reporting) PTC Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 8:02 AM | FMR LLC (Filed by) PTC Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2023 3:16 PM | PTC Therapeutics (Filer)
| Form POSASR | |
10/30/2023 8:05 AM | Camber Capital Management LP (Filed by) PTC Therapeutics (Subject)
| Form SC 13G | |
10/26/2023 3:34 PM | PTC Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/19/2023 3:15 PM | PTC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/19/2023 7:03 AM | PTC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/28/2023 3:45 PM | PTC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/22/2023 8:00 AM | PTC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/15/2023 5:15 AM | PTC Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |